TME Pharma extends financial visibility by lengthening debt maturity to June 2028
TME Pharma extends debt maturity to June 2028 and secures new bond financing to minimize shareholder dilution while advancing NOX-A12 licensing discussions
Covered in this story
Call it yourself
No calls on $TME yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tencent Music Entertainment →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.